We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Amgen Ponders Whether To Seek Injunction

Law360 (February 8, 2007, 12:00 AM EST) -- Amgen Inc., which is embroiled in a patent infringement dispute with rival drug maker Roche Holding AG, said Thursday it is not yet sure whether to seek a preliminary injunction in the case.

Speaking at a Merrill Lynch conference, Amgen CEO Kevin Sharer acknowledged that a preliminary injunction would stop Roche from immediately launching its Mircera anemia drug. He added, however, that there were two main challenges to procuring an injunction.

“The judge could say, ‘Look, I don’t really want to hear this case twice,’” Sharer...
To view the full article, register now.